Home
Categories
EXPLORE
Comedy
Music
Society & Culture
True Crime
History
Business
Religion & Spirituality
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/69/2b/e8/692be868-cca2-9a0a-26b8-921eb1136563/mza_4007809070306160451.png/600x600bb.jpg
Bench to Bedside
The University of Kansas Cancer Center
86 episodes
2 weeks ago
The University of Kansas Cancer Center's podcast Bench to Bedside provides a glimpse into the latest research discoveries that are transforming cancer care. Join Roy Jensen, MD, vice chancellor and director of the cancer center, weekly to hear from the top experts in the field as well as patients and caregivers.
Show more...
Medicine
Health & Fitness,
Nutrition
RSS
All content for Bench to Bedside is the property of The University of Kansas Cancer Center and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The University of Kansas Cancer Center's podcast Bench to Bedside provides a glimpse into the latest research discoveries that are transforming cancer care. Join Roy Jensen, MD, vice chancellor and director of the cancer center, weekly to hear from the top experts in the field as well as patients and caregivers.
Show more...
Medicine
Health & Fitness,
Nutrition
https://static.libsyn.com/p/assets/1/5/f/d/15fd6ed908d1ec53d959afa2a1bf1c87/KUCC_Bench-Bedside_COVER-20250611-3hezg9k5dm.png
Advancing Progress Against Brain Cancer with Cell Therapy
Bench to Bedside
19 minutes 27 seconds
5 months ago
Advancing Progress Against Brain Cancer with Cell Therapy
Bench to Bedside
The University of Kansas Cancer Center's podcast Bench to Bedside provides a glimpse into the latest research discoveries that are transforming cancer care. Join Roy Jensen, MD, vice chancellor and director of the cancer center, weekly to hear from the top experts in the field as well as patients and caregivers.